You are here: Welcome » OPTIONS for the Control of Influenza

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Both sides next revision
options_for_the_control_of_influenza [2022/10/27 03:20]
liam [OPTIONS IX] 		options_for_the_control_of_influenza [2022/10/27 03:22] (current)
liam [OPTIONS IX]
Line 108: Line 108:
  
 Exhibitors at OPTIONS IX include:((//Exhibit Opportunities.// Options IX. Retrieved July 6, 2017, from https://web.archive.org/web/20170706213219/http://2016.isirv.org/exhibit-opportunities)) Exhibitors at OPTIONS IX include:((//Exhibit Opportunities.// Options IX. Retrieved July 6, 2017, from https://web.archive.org/web/20170706213219/http://2016.isirv.org/exhibit-opportunities))
 +
 +  * [[pharmaceutical_companies:Allergan]]
 +  * [[pharmaceutical_companies:Cellular Technology Limited]] (CTL)
 +  * [[medical_technology_companies:Cepheid]]
 +  * [[pharmaceutical_companies:Denka]]
 +  * [[GISAID]]
 +  * [[pharmaceutical_companies:hVIVO]]
 +  * [[IIT Research Institute]] (IITRI)
 +  * [[pharmaceutical_companies:InDevR]]
 +  * [[J. Craig Venter Institute]] (JCVI)
 +  * [[medical_technology_companies:Luminex]]
 +  * [[medical_technology_companies:Quidel]]
 +  * [[pharmaceutical_companies:Sanofi Pasteur]]
 +  * [[pharmaceutical_companies:Seqirus]]
 +  * [[pharmaceutical_companies:SGS]]
Back to top